|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00003772 |
|
Date of registration:
|
01/11/1999 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Quality-of-Life Assessment in Patients With Ovarian Cancer
|
|
Scientific title:
|
An International Field Study of the Reliability and Validity of a Disease-Specific Questionnaire Module (the QLQ-OV28) in Assessing the Quality of Life of Patients With Ovarian Cancer |
|
Date of first enrolment:
|
January 1999 |
|
Target sample size:
|
372 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00003772 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Austria
|
France
|
Spain
|
United Kingdom
| | | | |
|
Contacts
|
|
Name:
|
Ann Cull, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Edinburgh Cancer Centre at Western General Hospital |
| | |
|
Key inclusion & exclusion criteria
|
DISEASE CHARACTERISTICS: Diagnosis of ovarian epithelial carcinoma No prior participation
in this study as a member of a different group Group 1: Prior surgery required Scheduled
for first line chemotherapy No chemotherapy prior to surgery Group 2: Prior surgery
required Completion of 6 courses of first line platinum-based chemotherapy required within
8 weeks prior to study Group 3: Must have achieved complete response to first line therapy
At least 3 months since any therapy for cancer Prior surgery required Prior chemotherapy
allowed Prior radiotherapy allowed Group 4: Must have recurrent disease Scheduled for
chemotherapy Prior surgery required Prior chemotherapy allowed Prior radiotherapy allowed
PATIENT CHARACTERISTICS: Age: Any age Performance status: Not specified Life expectancy:
At least 3 months Hematopoietic: Not specified Hepatic: Not specified Renal: Not specified
Other: No concurrent malignancies except basal cell carcinoma of the skin No mental
disease or language barrier that would prevent compliance No concurrent participation in
any other quality of life study that might interfere with this study
PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: See Disease
Characteristics Endocrine therapy: Not specified Radiotherapy: See Disease Characteristics
Surgery: See Disease Characteristics
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Ovarian Cancer
|
|
Intervention(s)
|
|
Procedure: quality-of-life assessment
|
|
Secondary ID(s)
|
|
EORTC-15982
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|